Published in Cancer Weekly, January 24th, 2012
"The isocenter dose or D(95) of PTV or other important values were compared with and without an inhomogeneity correction using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.